Table 2.
Meta-node |
Number of full-length sequences CAZy/metagenomes/total |
Sequences with signal peptide |
Catalytic residues |
Phosphate-binding residues |
+1 subsite |
Predicted mechanism and linkage specificity |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Proton donor |
Putative base |
|||||||||||
C1 |
221/836/1057 |
No |
D |
_ |
R |
H |
R |
Y |
R |
D |
GPs-β-1–4 |
|
C2 |
268/757/1025 |
No |
D D104 |
_ |
R R168 |
H H231 |
R R59 |
Y Y103 |
R R150 |
D D304 |
GPs-β-1–4 |
|
C3 |
113/152/265 |
Yes |
D D142 |
D/E E227 |
_ |
_ |
R R89 |
E E141 |
K K199 |
D D363 |
GHs-β-1–2 |
|
C4 |
290/76/366 |
295/366 |
No |
D |
_ |
R |
H |
R |
E |
K |
D |
GPs-β-1–2 |
70/366 |
R |
E |
R |
D |
GPs-β-1–3 |
|||||||
C5 |
42/70/112 |
No |
D |
_ |
R |
H |
R |
E |
R |
D |
GPs-β-1–3 |
|
C6 |
85/0/85 |
No |
D |
_ |
R |
H |
R |
E |
K |
D |
GPs-β-1–2 |
|
UC1 |
31/66/97 |
No |
D |
_ |
R |
H |
R |
Y |
R |
D |
GPs-β-1–4 |
|
UC2 |
199/0/199 |
No |
D |
_ |
R |
H |
R |
E |
K |
D |
GPs-β-1–2 |
|
UC3 |
135/18/153 |
124/153 |
No |
D |
_ |
R |
H |
R/D |
E |
K |
D |
GPs-β-1–2 |
7/153 |
R/D |
E |
R |
D |
GPs-β-1–3 |
|||||||
14/153 |
R/D |
Y |
R |
GPs-β-1–4 |
||||||||
UC4 |
0/53/53 |
Yes |
_ |
_ |
_ |
_ |
S |
M |
N |
_ |
GHs |
|
UC5 |
61/0/61 |
No |
D |
_ |
R |
H |
R |
E |
K |
D |
GPs-β-1–2 |
|
UC6 |
0/11/11 |
No |
D |
_ |
R |
H |
R |
I |
R |
D |
GPs |
|
UC7 |
9/10/19 |
No |
D |
_ |
R |
H |
R |
E |
R |
D |
GPs-β-1–3 |
|
UC8 |
26/7/33 |
No |
D |
_ |
R |
H |
R |
E |
K |
D |
GPs-β-1–2 |
|
UC9 |
29/0/29 |
No |
D |
_ |
R |
H |
R |
E |
K |
D |
GPs-β-1–2 |